FDA Part 11 Policy Should Take Risk-Based Approach, PhRMA Says

FDA should revise its draft guidance on electronic records to take a risk-based approach that is in line with the agency's GMP initiative, PhRMA said in comments on FDA's Part 11 draft guidance